Follow us...


Search News Archives





View Channel

Laboratory Products



View Channel

Separation Science



View Channel

Microscopy | Image Analysis



View Channel

IT Solutions and Laboratory Automation



View Channel


Conferences | Events

Practical solutions for translational science from Randox Laboratories

randoxRandox Pharma Services was founded with such a translational mission, and for 30 years has been carrying out R&D, custom assay development and supplying diagnostic solutions; all underpinned by a strong commitment to collaborate with leading academic research centres and pharmaceutical companies globally. 

In recognition of the vital role biomarkers play in translational medicine, Randox Pharma Services supply an unrivalled range of single analyte and multiplex diagnostic kits direct to end user laboratories.  Indeed, even kits produced primarily for research come under the same scrutiny as any commercial IVD assay i.e. imprecision less than 10%, fully optimised to eliminate cross-reactivity and non-specific binding to name just a few of our stringent QA processes.

As a private company Randox Pharma Services can be flexible and are swift to focus our significant in-house resources and expertise towards any pressing healthcare need; with a particular focus on oncology, infectious disease and metabolic disorders.

To enable this Randox have developed Biochip Array Technology, a multiplex technology which allows the simultaneous detection of multiple biomarkers from a single patient sample. Given the increased value of multiple biomarkers to improve patient diagnosis, such a technology is the ideal ‘target platform' for translational science.  Already arrays have been developed which are applicable to a broad range of therapeutic areas, with applications including multiplex immunoassays and nucleic acid based SNP, mutation, gene expression and pathogen detection arrays. 

Randox Pharma Services also offer over 130 enzymatic, substrate and immunoturbidimetric assays on our class-leading range of RX Series chemistry analysers which provide quality results at every phase from pre-clinical testing through to the clinic.

With robust, fit-for-purpose assays a pre-requisite for research, biomarker validation and ultimately translational science, only an established clinical diagnostic company such as Randox has the scientific and regulatory experience required. All to meet the pressing need for the more rapid translation of novel biomarkers to clinical utility.

For more information please visit or contact us at

If you have not logged into the website then please enter your details below.


Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin


Request your free copies HERE




Popular this Month

Top 10 most popular articles this month


Today's Picks




Looking for a Supplier?

Search by company or by product


Company Name:






Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


Media Partners